(Reuters) – Warren Buffett’s Berkshire Hathaway said it sold 750,000 shares of DaVita between February 14 and 19, reducing its stake in the kidney dialysis services provider by about 2% to 35.14 million shares.
Berkshire disclosed the sales in a Wednesday night filing with the U.S. Securities and Exchange Commission. The selling followed Berkshire’s sale of 203,091 DaVita shares on February 11.
(Reporting by Jonathan Stempel in New York; Editing by Sandra Maler)
